REGENERON PHARMACEUTICALS, INC. Diluted Shares Outstanding (Weighted Average)
REGENERON PHARMACEUTICALS, INC. (REGN) reported Diluted Shares Outstanding (Weighted Average) of 106.00 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 106.00M shares, a 2.39% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 107.70M shares, a 3.15% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 107.70M shares, a 5.19% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 107.20M shares, a 7.75% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 108.60M shares, a 5.65% decline from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 115.10M shares, a 1.23% increase from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 113.70M shares, a 0.18% increase from fiscal 2022.
- REGENERON PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 113.50M shares, a 1.16% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 106.00M shares 10-Q · filed 2026-07-30 | 106.80M shares 10-Q · filed 2026-07-30 | 107.13M shares derived: average of 3 quarters · filed 2026-07-30 | 107.15M shares derived: average of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | 107.70M shares 10-Q · filed 2026-04-29 | 107.70M shares derived: average of 2 quarters · filed 2026-04-29 | 107.53M shares derived: average of 3 quarters · filed 2026-04-29 | 107.80M shares derived: average of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | 107.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | 107.45M shares derived: average of 2 quarters · filed 2026-02-04 | 107.83M shares derived: average of 3 quarters · filed 2026-07-30 | 108.60M shares 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | 107.20M shares 10-Q · filed 2025-10-28 | 107.90M shares derived: average of 2 quarters · filed 2026-07-30 | 108.90M shares 10-Q · filed 2025-10-28 | 110.15M shares derived: average of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | 108.60M shares 10-Q · filed 2026-07-30 | 109.90M shares 10-Q · filed 2026-07-30 | 111.13M shares derived: average of 3 quarters · filed 2026-07-30 | 112.40M shares derived: average of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | 111.20M shares 10-Q · filed 2026-04-29 | 112.40M shares derived: average of 2 quarters · filed 2026-04-29 | 113.67M shares derived: average of 3 quarters · filed 2026-04-29 | 114.10M shares derived: average of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | 113.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | 114.90M shares derived: average of 2 quarters · filed 2026-02-04 | 115.07M shares derived: average of 3 quarters · filed 2026-02-04 | 115.10M shares 10-K · filed 2026-02-04 | ||||
| 2024-09-30 | 116.20M shares 10-Q · filed 2025-10-28 | 115.80M shares derived: average of 2 quarters · filed 2025-10-28 | 115.60M shares 10-Q · filed 2025-10-28 | 115.10M shares derived: average of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | 115.40M shares 10-Q · filed 2025-08-01 | 115.30M shares 10-Q · filed 2025-08-01 | 114.73M shares derived: average of 3 quarters · filed 2026-02-04 | 114.40M shares derived: average of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | 115.10M shares 10-Q · filed 2025-04-29 | 114.40M shares derived: average of 2 quarters · filed 2026-02-04 | 114.07M shares derived: average of 3 quarters · filed 2026-02-04 | 114.03M shares derived: average of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | 113.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | 113.55M shares derived: average of 2 quarters · filed 2026-02-04 | 113.67M shares derived: average of 3 quarters · filed 2026-02-04 | 113.70M shares 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | 113.40M shares 10-Q · filed 2024-10-31 | 113.65M shares derived: average of 2 quarters · filed 2024-10-31 | 113.70M shares 10-Q · filed 2024-10-31 | 113.85M shares derived: average of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | 113.90M shares 10-Q · filed 2024-08-01 | 113.90M shares 10-Q · filed 2024-08-01 | 114.00M shares derived: average of 3 quarters · filed 2025-02-05 | 113.70M shares derived: average of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | 114.00M shares 10-Q · filed 2024-05-02 | 114.05M shares derived: average of 2 quarters · filed 2025-02-05 | 113.63M shares derived: average of 3 quarters · filed 2025-02-05 | 113.72M shares derived: average of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | 114.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | 113.45M shares derived: average of 2 quarters · filed 2025-02-05 | 113.63M shares derived: average of 3 quarters · filed 2025-02-05 | 113.50M shares 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | 112.80M shares 10-Q · filed 2023-11-02 | 113.40M shares derived: average of 2 quarters · filed 2023-11-02 | 113.30M shares 10-Q · filed 2023-11-02 | 113.33M shares derived: average of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | 114.00M shares 10-Q · filed 2023-08-03 | 113.60M shares 10-Q · filed 2023-08-03 | 113.50M shares derived: average of 3 quarters · filed 2024-02-05 | 113.60M shares derived: average of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | 113.10M shares 10-Q · filed 2023-05-04 | 113.25M shares derived: average of 2 quarters · filed 2024-02-05 | 113.47M shares derived: average of 3 quarters · filed 2024-02-05 | 112.80M shares derived: average of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | 113.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | 113.65M shares derived: average of 2 quarters · filed 2024-02-05 | 112.70M shares derived: average of 3 quarters · filed 2024-02-05 | 112.20M shares 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | 113.90M shares 10-Q · filed 2022-11-03 | 112.35M shares derived: average of 2 quarters · filed 2022-11-03 | 111.80M shares 10-Q · filed 2022-11-03 | 111.83M shares derived: average of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | 110.80M shares 10-Q · filed 2022-08-03 | 110.70M shares 10-Q · filed 2022-08-03 | 111.13M shares derived: average of 3 quarters · filed 2023-02-06 | 111.83M shares derived: average of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | 110.50M shares 10-Q · filed 2022-05-04 | 111.30M shares derived: average of 2 quarters · filed 2023-02-06 | 112.17M shares derived: average of 3 quarters · filed 2023-02-06 | 113.60M shares derived: average of 4 quarters · filed 2023-02-06 | ||||
| 2020-12-31 | 112.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | 113.00M shares derived: average of 2 quarters · filed 2023-02-06 | 114.63M shares derived: average of 3 quarters · filed 2023-02-06 | 115.10M shares 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | 113.90M shares 10-Q · filed 2021-11-04 | 115.90M shares derived: average of 2 quarters · filed 2021-11-04 | 116.10M shares 10-Q · filed 2021-11-04 | 115.30M shares derived: average of 4 quarters · filed 2022-02-07 | ||||
| 2020-06-30 | 117.90M shares 10-Q · filed 2021-08-05 | 116.80M shares 10-Q · filed 2021-08-05 | 115.77M shares derived: average of 3 quarters · filed 2022-02-07 | 115.38M shares derived: average of 4 quarters · filed 2022-02-07 | ||||
| 2020-03-31 | 115.10M shares 10-Q · filed 2021-05-06 | 114.70M shares derived: average of 2 quarters · filed 2022-02-07 | 114.53M shares derived: average of 3 quarters · filed 2022-02-07 | 114.55M shares derived: average of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | 114.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | 114.25M shares derived: average of 2 quarters · filed 2022-02-07 | 114.37M shares derived: average of 3 quarters · filed 2022-02-07 | 114.60M shares 10-K · filed 2022-02-07 | ||||
| 2019-09-30 | 114.20M shares 10-Q · filed 2020-11-05 | 114.40M shares derived: average of 2 quarters · filed 2020-11-05 | 114.70M shares 10-Q · filed 2020-11-05 | 114.78M shares derived: average of 4 quarters · filed 2021-02-08 | ||||
| 2019-06-30 | 114.60M shares 10-Q · filed 2020-08-05 | 115.00M shares 10-Q · filed 2020-08-05 | 114.97M shares derived: average of 3 quarters · filed 2021-02-08 | 115.00M shares derived: average of 4 quarters · filed 2021-02-08 | ||||
| 2019-03-31 | 115.50M shares 10-Q · filed 2020-05-05 | 115.15M shares derived: average of 2 quarters · filed 2021-02-08 | 115.13M shares derived: average of 3 quarters · filed 2021-02-08 | 114.97M shares derived: average of 4 quarters · filed 2021-02-08 | ||||
| 2018-12-31 | 114.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | 114.95M shares derived: average of 2 quarters · filed 2021-02-08 | 114.80M shares derived: average of 3 quarters · filed 2021-02-08 | 114.80M shares 10-K · filed 2021-02-08 | ||||
| 2018-09-30 | 115.10M shares 10-Q · filed 2019-11-05 | 115.09M shares 10-Q · filed 2018-11-06 | 114.80M shares derived: average of 2 quarters · filed 2019-11-05 | 114.80M shares 10-Q · filed 2019-11-05 | 114.84M shares 10-Q · filed 2018-11-06 | 115.03M shares derived: average of 4 quarters · filed 2020-02-07 | ||
| 2018-06-30 | 114.50M shares 10-Q · filed 2019-08-06 | 114.48M shares 10-Q · filed 2018-08-02 | 114.70M shares 10-Q · filed 2019-08-06 | 114.70M shares 10-Q · filed 2018-08-02 | 115.01M shares derived: average of 3 quarters · filed 2020-02-07 | 115.51M shares derived: average of 4 quarters · filed 2020-02-07 | ||
| 2018-03-31 | 114.90M shares 10-Q · filed 2019-05-07 | 114.91M shares 10-Q · filed 2018-05-03 | 115.26M shares derived: average of 2 quarters · filed 2020-02-07 | 115.85M shares derived: average of 3 quarters · filed 2020-02-07 | 115.92M shares derived: average of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | 115.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | 116.32M shares derived: average of 2 quarters · filed 2020-02-07 | 116.26M shares derived: average of 3 quarters · filed 2020-02-07 | 115.90M shares 10-K · filed 2020-02-07 | 115.95M shares 10-K · filed 2018-02-08 | |||
| 2017-09-30 | 117.03M shares 10-Q · filed 2018-11-06 | 116.58M shares derived: average of 2 quarters · filed 2018-11-06 | 115.99M shares 10-Q · filed 2018-11-06 | 115.94M shares derived: average of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | 116.14M shares 10-Q · filed 2018-08-02 | 115.61M shares 10-Q · filed 2018-08-02 | 115.58M shares derived: average of 3 quarters · filed 2019-02-07 | 115.80M shares derived: average of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | 115.11M shares 10-Q · filed 2018-05-03 | 115.30M shares derived: average of 2 quarters · filed 2019-02-07 | 115.69M shares derived: average of 3 quarters · filed 2019-02-07 | 115.83M shares derived: average of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | 115.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | 115.98M shares derived: average of 2 quarters · filed 2019-02-07 | 116.07M shares derived: average of 3 quarters · filed 2019-02-07 | 116.30M shares 10-K · filed 2019-02-07 | 116.37M shares 10-K · filed 2017-02-09 | |||
| 2016-09-30 | 116.47M shares 10-Q · filed 2017-11-08 | 116.35M shares derived: average of 2 quarters · filed 2017-11-08 | 116.57M shares 10-Q · filed 2017-11-08 | 115.60M shares derived: average of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | 116.23M shares 10-Q · filed 2017-08-03 | 116.62M shares 10-Q · filed 2017-08-03 | 115.32M shares derived: average of 3 quarters · filed 2018-02-08 | 115.47M shares derived: average of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | 114.23M shares 10-Q · filed 2017-05-04 | 114.86M shares derived: average of 2 quarters · filed 2018-02-08 | 115.22M shares derived: average of 3 quarters · filed 2018-02-08 | 115.23M shares derived: average of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | 115.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | 115.72M shares derived: average of 2 quarters · filed 2018-02-08 | 115.56M shares derived: average of 3 quarters · filed 2018-02-08 | 115.23M shares 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | 115.94M shares 10-Q · filed 2016-11-04 | 115.60M shares derived: average of 2 quarters · filed 2016-11-04 | 115.14M shares 10-Q · filed 2016-11-04 | 114.94M shares derived: average of 4 quarters · filed 2017-02-09 | ||||
| 2015-06-30 | 115.26M shares 10-Q · filed 2016-08-04 | 114.96M shares 10-Q · filed 2016-08-04 | 114.61M shares derived: average of 3 quarters · filed 2017-02-09 | 115.31M shares derived: average of 4 quarters · filed 2017-02-09 | ||||
| 2015-03-31 | 114.52M shares 10-Q · filed 2016-05-05 | 114.28M shares derived: average of 2 quarters · filed 2017-02-09 | 115.33M shares derived: average of 3 quarters · filed 2017-02-09 | 114.75M shares derived: average of 4 quarters · filed 2017-02-09 | ||||
| 2014-12-31 | 114.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | 115.73M shares derived: average of 2 quarters · filed 2017-02-09 | 114.83M shares derived: average of 3 quarters · filed 2017-02-09 | 113.41M shares 10-K · filed 2017-02-09 | ||||
| 2014-09-30 | 117.42M shares 10-Q · filed 2015-11-04 | 115.23M shares derived: average of 2 quarters · filed 2015-11-04 | 113.20M shares 10-Q · filed 2015-11-04 | 110.28M shares derived: average of 4 quarters · filed 2016-02-11 | ||||
| 2014-06-30 | 113.03M shares 10-Q · filed 2015-08-04 | 113.12M shares 10-Q · filed 2015-08-04 | 107.89M shares derived: average of 3 quarters · filed 2016-02-11 | 110.10M shares derived: average of 4 quarters · filed 2016-02-11 | ||||
| 2014-03-31 | 112.15M shares 10-Q · filed 2015-05-07 | 105.32M shares derived: average of 2 quarters · filed 2016-02-11 | 109.12M shares derived: average of 3 quarters · filed 2016-02-11 | 109.61M shares derived: average of 4 quarters · filed 2016-02-11 | ||||
| 2013-12-31 | 98.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | 107.61M shares derived: average of 2 quarters · filed 2016-02-11 | 108.76M shares derived: average of 3 quarters · filed 2016-02-11 | 111.29M shares 10-K · filed 2016-02-11 | ||||
| 2013-09-30 | 116.71M shares 10-Q · filed 2014-11-04 | 113.89M shares derived: average of 2 quarters · filed 2014-11-04 | 115.55M shares 10-Q · filed 2014-11-04 | 117.33M shares derived: average of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | 111.06M shares 10-Q · filed 2014-08-05 | 110.31M shares 10-Q · filed 2014-08-05 | 117.54M shares derived: average of 3 quarters · filed 2015-02-12 | 117.11M shares derived: average of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | 109.37M shares 10-Q · filed 2014-05-08 | 120.78M shares derived: average of 2 quarters · filed 2015-02-12 | 119.13M shares derived: average of 3 quarters · filed 2015-02-12 | 116.89M shares derived: average of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | 132.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | 124.01M shares derived: average of 2 quarters · filed 2015-02-12 | 119.39M shares derived: average of 3 quarters · filed 2015-02-12 | 115.38M shares 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | 115.83M shares 10-Q · filed 2013-11-05 | 113.00M shares derived: average of 2 quarters · filed 2013-11-05 | 109.78M shares 10-Q · filed 2013-11-05 | 106.38M shares derived: average of 4 quarters · filed 2014-02-13 | ||||
| 2012-06-30 | 110.17M shares 10-Q · filed 2013-08-06 | 109.00M shares 10-Q · filed 2013-08-06 | 103.23M shares derived: average of 3 quarters · filed 2014-02-13 | 100.19M shares derived: average of 4 quarters · filed 2014-02-13 | ||||
| 2012-03-31 | 107.73M shares 10-Q · filed 2013-05-03 | 99.76M shares derived: average of 2 quarters · filed 2014-02-13 | 96.86M shares derived: average of 3 quarters · filed 2014-02-13 | 95.25M shares derived: average of 4 quarters · filed 2014-02-13 | ||||
| 2011-12-31 | 91.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | 91.42M shares derived: average of 2 quarters · filed 2014-02-13 | 91.09M shares derived: average of 3 quarters · filed 2014-02-13 | 90.61M shares 10-K · filed 2014-02-13 | ||||
| 2011-09-30 | 91.05M shares 10-Q · filed 2012-10-24 | 90.74M shares derived: average of 2 quarters · filed 2012-10-24 | 90.22M shares 10-Q · filed 2012-10-24 | |||||
| 2011-06-30 | 90.44M shares 10-Q · filed 2012-07-25 | 89.80M shares 10-Q · filed 2012-07-25 | ||||||
| 2011-03-31 | 89.16M shares 10-Q · filed 2012-04-26 | |||||||
| 2010-12-31 | 82.93M shares 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |